A NEW blood test could detect Alzheimer’s disease in its early stages, years before symptoms begin to show. Tests that ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced data that reinforces the therapeutic potential of IGC-AD1 as a disease-modifying treatment for Alzheimer's disease. The data highlights ...

ROCKVILLE, Md., Sept. 18, 2024 /PRNewswire/ -- Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, is expanding its operations in Europe through a ...

Westend61/Getty Images A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

Education and early detection of any type of dementia is important and may provide an opportunity for changing the course of ...

Education and early detection of any dementia is important and may provide an opportunity to change the course of care, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Darmiyan, Inc., a pioneer in brain technology, is proud to announce the launch of the BrainSee Platform, integrating the first-of-its-kind FDA-approved BrainSee Test for Alzheimer's disease. This ...

In the U.S., more than 6 million people have Alzheimer's disease and related dementias ... of its full potential in care quality assessment. Traditional disease-focused AI models are becoming outdated ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.